Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Novartis Foundation Symposium|February 28, 2008
The role of Egfl7 in vascular morphogenesisMaike Schmidt, Ann De Mazière, Tanya Smyczek, et al.Cell|October 20, 2009
TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signalingHarald J Junge, Stacey Yang, Jeremy B Burton, et al.Science Signaling|October 2, 2008
Kinome siRNA screen identifies regulators of ciliogenesis and hedgehog signal transductionMarie Evangelista, Tze Yang Lim, James Lee, et al.Development (Cambridge, England)|August 12, 2021
Control of dynamic cell behaviors during angiogenesis and anastomosis by Rasip1Minkyoung Lee, Charles Betz, Jianmin Yin, et al.Development (Cambridge, England)|July 13, 2007
EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distributionMaike Schmidt, Kim Paes, Ann De Mazière, et al.Nature|March 25, 2015
MAP4K4 regulates integrin-FERM binding to control endothelial cell motilityPhilip Vitorino, Stacey Yeung, Ailey Crow, et al.The American Journal of Pathology|October 28, 2003
Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosisFiona Oakley, Nathan Trim, Christothea M Constandinou, et al.Science Immunology|March 30, 2020
MAP4K4 negatively regulates CD8 T cell-mediated antitumor and antiviral immunityEmel Esen, Ismail Sergin, Rajiv Jesudason, et al.Nature|April 16, 2004
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formationLeon H Parker, Maike Schmidt, Suk-Won Jin, et al.The Oncologist|February 14, 2018
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung CancerJoachim von Pawel, David R Spigel, Thomas Ervin, et al.Pageof 4